Texas OK’s $50 Million for Ibogaine Research
Texas OK’s $50 Million for Ibogaine Research The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans
Ibogaine as a Treatment for Parkinson’s Disease
Ibogaine as a Treatment for Parkinson’s Disease Over 55 million people worldwide are affected by neurodegenerative diseases, such as Alzheimer’s, multiple sclerosis, and Parkinson’s, which
Ibogaine and Parkinson’s Disease
Ibogaine and Parkinson’s Disease After Alzheimer’s, Parkinson’s Disease is the second most common neurodegenerative disease and is currently not curable. The disease manifests itself by
Ibogaine: A Potential Parkinson’s Treatment?
Does Ibogaine work for Parkinson’s Disease? Ibogaine has been used for years in the treatment of Substance Use Disorders, which are often associated with drugs
lbogaine: a polydrug- effective addiction interrupter Why Vermont should include Ibogaine in its opioid addiction treatment strategy presentation prepared by Vermonters for Ibogaine
Ibogaine: a polydrug- effective addiction interrupter Why Vermont should include Ibogaine in its opioid addiction treatment strategy presentation prepared by Vermonters for lbogaine Research
Could Ibogaine Be A Promising New Treatment For Parkinson’s Disease?
A research team at Columbia University soon hopes to show whether or not ibogaine, an extract of iboga — a psychoactive West-African plant medicine